Log In
Print
BCIQ
Print
Print this Print this
 

SX-PCK9

  Manage Alerts
Collapse Summary General Information
Company Serometrix LLC
DescriptionProprotein convertase subtilisin/kexin type 9 (PCSK9) antagonist
Molecular Target Proprotein convertase subtilisin/kexin type 9 (PCSK9)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationHypercholesterolemia
Indication DetailsTreat hypercholesterolemia
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today